Inventaire - your friends and communities are your best library

Developing an HPV vaccine to prevent cervical cancer and genital warts

published in: Vaccine

date of publication: 2007-01-18

language: English

main subject: vaccine, HPV vaccine, cervical uterine cancer

Cites articles 32

Date

Title

Authors

2006-01-01

Genital human papillomavirus infection in men.

Laura Koutsky
2006-11

Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women

Xavier Castellsagué, Colin D Marchant, Terry Nolan
2005-07-01

Stabilization of human papillomavirus virus-like particles by non-ionic surfactants
2005-08-01

Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18

Kathrin Jansen
2005-05-01

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

Finn Egil Skjeldestad, Cosette M Wheeler, Kathrin Jansen, Laura Koutsky
2004-04-20

Can genital-tract human papillomavirus infection and cervical cancer be prevented with a vaccine?

Joakim Dillner
2004-07-01

Early assessment of the efficacy of a human papillomavirus type 16 L1 virus-like particle vaccine

Cosette M Wheeler, Kathrin Jansen, Laura Koutsky
2004-08-01

A phase I study to evaluate a human papillomavirus (HPV) type 18 L1 VLP vaccine

Anna R Giuliano, Kathrin Jansen
2004-07-01

Dose-ranging studies of the safety and immunogenicity of human papillomavirus Type 11 and Type 16 virus-like particle candidate vaccines in young healthy women.

Cosette M Wheeler, Kathrin Jansen, Nancy B Kiviat, Laura Koutsky
2003-02-06

Epidemiologic classification of human papillomavirus types associated with cervical cancer

Francesc Xavier Bosch José, Xavier Castellsagué, Peter J F Snijders
2003-10-01

Adjuvant synergy in the response to hepatitis B vaccines
2003-01-01

Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16, and 18 by a multiplexed luminex assay

Kathrin Jansen
2002-02-01

A population-based study of squamous cell vaginal cancer: HPV and cofactors

Janet Daling, Peggy L. Porter, Denise Galloway
2002-10-01

External genital warts: diagnosis, treatment, and prevention

Dorothy J Wiley
2002-11-01

A controlled trial of a human papillomavirus type 16 vaccine

Cosette M Wheeler, Kathrin Jansen, Laura Koutsky
2002-05-01

Mechanisms of stimulation of the immune response by aluminum adjuvants
2002-04-01

The 2001 Bethesda System: terminology for reporting results of cervical cytology
2000-10-01

Recurrent respiratory papillomatosis of the larynx: current diagnosis and treatment
2000-02-01

Pathogenesis and treatment of juvenile onset recurrent respiratory papillomatosis

Richard J Smith
1999-09

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

Francesc Xavier Bosch José
1999-12-01

Purification of virus-like particles of recombinant human papillomavirus type 11 major capsid protein L1 from Saccharomyces cerevisiae
1997-10-01

Cofactors with human papillomavirus in a population-based study of vulvar cancer

Janet Daling, Denise Galloway
1996-03-01

Sequence conservation within the major capsid protein of human papillomavirus (HPV) type 18 and formation of HPV-18 virus-like particles in Saccharomyces cerevisiae
1996-11-01

Expression of the major capsid protein of human papillomavirus type 11 in Saccharomyces cerevisae
1996-09-01

Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies

Denise Galloway
1995-06-01

Sequence determination of human papillomavirus type 6a and assembly of virus-like particles in Saccharomyces cerevisiae
1994-04-01

Effect of protein adsorption on the surface charge characteristics of aluminium-containing adjuvants
1994-11-01

Human papillomavirus types 6 and 11 have antigenically distinct strongly immunogenic conformationally dependent neutralizing epitopes
1993-10-01

Analysis of human papillomavirus types in exophytic condylomata acuminata by hybrid capture and Southern blot techniques
1991-11-01

Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles

Ian Frazer
1990-12-01

Aluminum compounds used as adjuvants in vaccines
1990-11-01

Monoclonal antibody-mediated neutralization of infectious human papillomavirus type 11

Article - wd:Q36731663

Welcome to Inventaire

the library of your friends and communities

learn more